Source link : https://www.newshealth.biz/health-news/medicare-lags-medicaid-leads-for-biosimilar-uptake/
Infliximab biosimilars have taken an increasing share of prescriptions for the first tumor necrosis factor (TNF) inhibitor to win approval, but some payers have been more willing than others to cover these products — with the U.S. government so far being the least willing. From 2016 to 2022, private insurance, Medicaid, and Medicare all substantially […]
Author : News Health
Publish date : 2024-08-02 14:00:00
Copyright for syndicated content belongs to the linked Source.
Categories